Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-052046
Filing Date
2023-04-28
Accepted
2023-04-28 07:04:25
Documents
4
Period of Report
2023-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2314078d1_6k.htm 6-K 10649
2 EXHIBIT 99.1 tm2314078d1_ex99-1.htm EX-99.1 14481
3 GRAPHIC tm2314078d1_ex99-1img001.jpg GRAPHIC 4051
4 GRAPHIC tm2314078d1_ex99-1img002.jpg GRAPHIC 3930
  Complete submission text file 0001104659-23-052046.txt   37535
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 23860097
SIC: 2834 Pharmaceutical Preparations